Schonfeld Strategic Advisors LLC Veracyte, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 46,820 shares of VCYT stock, worth $1.46 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,820
Previous 15,599
200.15%
Holding current value
$1.46 Million
Previous $530,000
249.81%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
76.3MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$255 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$242 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$205 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$131 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$95.8 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.23B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...